Paper39633459
Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV.
Lei Z and 10 others. Virol J, 2024. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV. Papers, record 39633459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39633459
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis B virus | Major topic |
| Hepatitis B, Chronic | Major topic |
| Interferon-alpha | Major topic |
| Humans | |
| Hepatitis B | |
| Interferons | |
| Signal Transduction | |
| Treatment Outcome | |
| Virus Replication |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82060304 | National Natural Science Foundation of China | PubMed | ||
| KXJ1723105 | Talent Introduction Project of Zhejiang Shuren University | PubMed | ||
| 2024XZ013 | Zhejiang Shuren University Basic Scientific Research Special Funds | PubMed |
Source PubMed
References137
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8328741 | Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8328741 | PubMed |
| 2 | 29679386 | Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes. | Hepatology | 2018 | https://conductscience.org/library/papers/29679386 | PubMed |
| 3 | 23332086 | A multicenter survey of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan. | Hepatol Res | 2013 | https://conductscience.org/library/papers/23332086 | PubMed |
| 4 | 21478870 | A diverse range of gene products are effectors of the type I interferon antiviral response. | Nature | 2011 | https://conductscience.org/library/papers/21478870 | PubMed |
| 5 | 24604126 | Recent insights into hepatitis B virus-host interactions. | J Med Virol | 2014 | https://conductscience.org/library/papers/24604126 | PubMed |
| 6 | 27003258 | HBsAg blocks TYPE I IFN induced up-regulation of A3G through inhibition of STAT3. | Biochem Biophys Res Commun | 2016 | https://conductscience.org/library/papers/27003258 | PubMed |
| 7 | 29456079 | Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B. | J Formos Med Assoc | 2018 | https://conductscience.org/library/papers/29456079 | PubMed |
| 8 | 21334391 | The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. | J Hepatol | 2011 | https://conductscience.org/library/papers/21334391 | PubMed |
| 9 | 33845868 | Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus. | Gut Pathog | 2021 | https://conductscience.org/library/papers/33845868 | PubMed |
| 10 | 2732449 | Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon. | J Hepatol | 1989 | https://conductscience.org/library/papers/2732449 | PubMed |
| 11 | 28139375 | Transcriptional Regulation of Antiviral Interferon-Stimulated Genes. | Trends Microbiol | 2017 | https://conductscience.org/library/papers/28139375 | PubMed |
| 12 | 10756029 | Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. | J Virol | 2000 | https://conductscience.org/library/papers/10756029 | PubMed |
| 13 | 26566064 | AASLD guidelines for treatment of chronic hepatitis B. | Hepatology | 2016 | https://conductscience.org/library/papers/26566064 | PubMed |
| 14 | 15031497 | Inhibition of hepatitis B virus replication by APOBEC3G. | Science | 2004 | https://conductscience.org/library/papers/15031497 | PubMed |
| 15 | 29715359 | Chronic Hepatitis B Infection: A Review. | JAMA | 2018 | https://conductscience.org/library/papers/29715359 | PubMed |
| 16 | 26134841 | Hepadnavirus Genome Replication and Persistence. | Cold Spring Harb Perspect Med | 2015 | https://conductscience.org/library/papers/26134841 | PubMed |
| 17 | 28432378 | Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway. | Cell Mol Life Sci | 2017 | https://conductscience.org/library/papers/28432378 | PubMed |
| 18 | 27283515 | The APOBEC Protein Family: United by Structure, Divergent in Function. | Trends Biochem Sci | 2016 | https://conductscience.org/library/papers/27283515 | PubMed |
| 19 | 38336347 | Major HBV splice variant encoding a novel protein important for infection. | J Hepatol | 2024 | https://conductscience.org/library/papers/38336347 | PubMed |
| 20 | 1060140 | Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1060140 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42828128 | PYHIN proteins: guardians or contributors to hepatitis B virus pathogenesis? | Front Immunol | 2026 | https://conductscience.org/library/papers/42828128 | PubMed |
| 42510927 | Liver Macrophages in the Pathogenesis of Viral Hepatitis. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42510927 | PubMed |
| 42503914 | [Advancement in the role of exosomes for hepatitis B virus infection diagnosis and treatment: mechanisms and clinical applications]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42503914 | PubMed |
| 42246003 | Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAg. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42246003 | PubMed |
| 42209159 | [Expert recommendations on the management of adverse reactions in pegylated interferon alpha therapy for chronic hepatitis B]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42209159 | PubMed |
| 42075882 | Repurposing Product Nkabinde for Hepatitis B Virus Therapy: A Network Pharmacology and Molecular Docking Investigation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075882 | PubMed |
| 42021267 | Predictive value and mechanism of LINC00665 for liver dysfunction in pregnant women with hepatitis B during early pregnancy. | Virol J | 2026 | https://conductscience.org/library/papers/42021267 | PubMed |
| 42016067 | Precise delivery of medical gases by engineered nanomedicine for enhanced liver fibrosis therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42016067 | PubMed |
| 41924278 | Interferon therapy for chronic hepatitis B in children: an immunological perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/41924278 | PubMed |
| 41514917 | Hepatic Macrophages in Chronic Hepatitis B: Balancing Immunity and Pathology. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41514917 | PubMed |
| 41179730 | Hepatitis B functional cure: Current and future perspective. | World J Hepatol | 2025 | https://conductscience.org/library/papers/41179730 | PubMed |
| 41014398 | Do the therapeutic vaccines hold hope for the treatment of hepatitis B? | Hepatol Int | 2025 | https://conductscience.org/library/papers/41014398 | PubMed |
| 40772275 | Genetic association between STAT4 and primary Sjögren's syndrome in Han Chinese women. | Front Genet | 2025 | https://conductscience.org/library/papers/40772275 | PubMed |
| 40771315 | Exosome in HBV infection: current concepts and future perspectives. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40771315 | PubMed |
| 40655152 | Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances. | Front Immunol | 2025 | https://conductscience.org/library/papers/40655152 | PubMed |
| 40408617 | Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B. | PLoS One | 2025 | https://conductscience.org/library/papers/40408617 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| KRT88P | 85348 | PubTator's text mining | https://conductscience.org/library/genes/85348 | NCBI Gene |
| STAT1 | 6772 | PubTator's text mining | https://conductscience.org/library/genes/6772 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39633459
GET https://conductscience.org/api/papers/v1/39633459/references?page=2